A Novel 5-Methylcytosine- and Immune-Related Prognostic Signature Is a Potential Marker of Idiopathic Pulmonary Fibrosis

Figure 8

The potential molecular mechanisms of m5CPS in IPF. (a) Selection of overlap molecular functions of m5CPS in the three cohorts. (b) The overlap molecular functions of m5CPS in the three cohorts; the panel was drawn based on the validation cohort. (c) KEGG signaling pathways of m5CPS based on the three cohorts. (d) Selection of KEGG signaling pathways of m5CPS in the three cohorts. (e) The immune cell fraction levels between patients with high- and low-risk scores; value was calculated based on Wilcoxon rank-sum tests.

(a)

(b)

(c)

(d)

(e)